XAIR: Beyond Air Inc. Stocks News on August 24, 2025

XAIR

GuruFocus.com

11 days ago

Beyond Air Inc (XAIR) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic Expansion ...

XAIR

Zacks

11 days ago

Beyond Air, Inc. (XAIR) Reports Q1 Loss, Lags Revenue Estimates

Beyond Air® Reports Fiscal First Quarter 2026 Financial Results and Provides Corporate Update

XAIR

GlobeNewswire

11 days ago

Beyond Air® Reports Fiscal First Quarter 2026 Financial Results and Provides Corporate Update

XAIR

GuruFocus.com

13 days ago

Beyond Air Inc (XAIR) Q1 2026 Earnings Report Preview: What To Expect

XAIR

Zacks

2 months ago

Here's Why Beyond Air (XAIR) Could be Great Choice for a Bottom Fisher

Beyond Air Full Year 2025 Earnings: EPS Beats Expectations, Revenues Lag

XAIR

Simply Wall St.

2 months ago

Beyond Air Full Year 2025 Earnings: EPS Beats Expectations, Revenues Lag

XAIR

GuruFocus.com

2 months ago

Beyond Air Inc (XAIR) (Q4 2025) Earnings Call Highlights: Revenue Soars Amidst Strategic Global ...

Beyond Air® Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

XAIR

GlobeNewswire

2 months ago

Beyond Air® Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

XAIR

GuruFocus.com

2 months ago

Beyond Air Inc (XAIR) Q4 2025 Earnings Report Preview: What To Look For

Beyond Air Submits FDA PMA Supplement for Next Generation LungFit® PH

XAIR

GlobeNewswire

2 months ago

Beyond Air Submits FDA PMA Supplement for Next Generation LungFit® PH

Beyond Air Schedules Fiscal Year End 2025 Financial Results Conference Call and Webcast

XAIR

GlobeNewswire

3 months ago

Beyond Air Schedules Fiscal Year End 2025 Financial Results Conference Call and Webcast

Beyond Air Granted U.S. Patent Covering Treatment of NTM Infections Using gaseous Nitric Oxide (gNO)

XAIR

GlobeNewswire

4 months ago

Beyond Air Granted U.S. Patent Covering Treatment of NTM Infections Using gaseous Nitric Oxide (gNO)

NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism

XAIR

GlobeNewswire

4 months ago

NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism

NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board

XAIR

GlobeNewswire

4 months ago

NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board

Beyond Air Publishes Article in Annals of the American Thoracic Society Journal Highlighting NTM-PD Patients’ Ability to Safely Self-Administer High-Dose Intermittent iNO Treatments Using the LungFit™ GO at Home

XAIR

GlobeNewswire

4 months ago

Beyond Air Publishes Article in Annals of the American Thoracic Society Journal Highlighting NTM-PD Patients’ Ability to Safely Self-Administer High-Dose Intermittent iNO Treatments Using the LungFit™ GO at Home

NeuroNOS Announces Groundbreaking Research Publication by its CSO Demonstrating Mechanism of Action in Alzheimer’s Disease and Reinforcing Platform’s Strength Across Neurological Disorders

XAIR

GlobeNewswire

5 months ago

NeuroNOS Announces Groundbreaking Research Publication by its CSO Demonstrating Mechanism of Action in Alzheimer’s Disease and Reinforcing Platform’s Strength Across Neurological Disorders

Beyond Air Announces Vanderbilt University Medical Center as First Luminary Site

XAIR

GlobeNewswire

5 months ago

Beyond Air Announces Vanderbilt University Medical Center as First Luminary Site

NeuroNOS Secures $2.0 Million in Funding to Advance Development of an Innovative Autism Therapy

XAIR

GlobeNewswire

5 months ago

NeuroNOS Secures $2.0 Million in Funding to Advance Development of an Innovative Autism Therapy

Beyond Air Announces Agreements Expanding Global Distribution of LungFit® PH

XAIR

GlobeNewswire

5 months ago

Beyond Air Announces Agreements Expanding Global Distribution of LungFit® PH

Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences

XAIR

GlobeNewswire

6 months ago

Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences

Beyond Air Third Quarter 2025 Earnings: Beats Expectations

XAIR

Simply Wall St.

6 months ago

Beyond Air Third Quarter 2025 Earnings: Beats Expectations

Beyond Air® Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update

XAIR

GlobeNewswire

6 months ago

Beyond Air® Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update

XAIR

GuruFocus.com

7 months ago

Beyond Air Inc (XAIR) Q3 2025 Earnings Report Preview: What To Expect

Beyond Air® Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement

XAIR

GlobeNewswire

7 months ago

Beyond Air® Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement

Beyond Air® Schedules Third Fiscal Quarter 2025 Financial Results Conference Call and Webcast

XAIR

GlobeNewswire

7 months ago

Beyond Air® Schedules Third Fiscal Quarter 2025 Financial Results Conference Call and Webcast

Beyond Air® Announces LungFit® PH Receives Market Authorization in Australia

XAIR

GlobeNewswire

7 months ago

Beyond Air® Announces LungFit® PH Receives Market Authorization in Australia

Insider Stock Buying Reaches US$1.60m On Beyond Air

XAIR

Simply Wall St.

7 months ago

Insider Stock Buying Reaches US$1.60m On Beyond Air

Beyond Air to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

XAIR

GlobeNewswire

8 months ago

Beyond Air to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1b Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) in Combination with Anti-PD-1 Therapy

XAIR

GlobeNewswire

9 months ago

Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1b Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) in Combination with Anti-PD-1 Therapy

Beyond Air Receives CE Mark in Europe for the LungFit® PH System

XAIR

GlobeNewswire

9 months ago

Beyond Air Receives CE Mark in Europe for the LungFit® PH System

NeuroNOS Appoints Nobel Laureate, Roger D. Kornberg, to Scientific Advisory Board

XAIR

GlobeNewswire

9 months ago

NeuroNOS Appoints Nobel Laureate, Roger D. Kornberg, to Scientific Advisory Board

Beyond Air to Participate in the Piper Sandler 36th Annual Healthcare Conference

XAIR

GlobeNewswire

9 months ago

Beyond Air to Participate in the Piper Sandler 36th Annual Healthcare Conference

Beyond Air® Reports Fiscal Second Quarter 2025 Financial Results and Provides Corporate Update

XAIR

GlobeNewswire

9 months ago

Beyond Air® Reports Fiscal Second Quarter 2025 Financial Results and Provides Corporate Update

Beyond Cancer Presents Promising Preclinical Data on Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

XAIR

GlobeNewswire

9 months ago

Beyond Cancer Presents Promising Preclinical Data on Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

XAIR

GuruFocus.com

10 months ago

Beyond Air Inc (XAIR) Q2 2025 Earnings Report Preview: What To Expect

Beyond Air® Schedules Second Fiscal Quarter 2025 Financial Results Conference Call and Webcast

XAIR

GlobeNewswire

10 months ago

Beyond Air® Schedules Second Fiscal Quarter 2025 Financial Results Conference Call and Webcast

Beyond Cancer to Present Preclinical Data of Ultra-High Concentration Nitric Oxide (UNO) Low Volume Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

XAIR

GlobeNewswire

a year ago

Beyond Cancer to Present Preclinical Data of Ultra-High Concentration Nitric Oxide (UNO) Low Volume Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Beyond Air Partners with Healthcare Links to Expand Access to LungFit® PH System Through Group Purchasing Organizations and Integrated Delivery Networks

XAIR

GlobeNewswire

a year ago

Beyond Air Partners with Healthcare Links to Expand Access to LungFit® PH System Through Group Purchasing Organizations and Integrated Delivery Networks

Beyond Air to sell 40.39M shares at 51c in private placement

XAIR

TipRanks

a year ago

Beyond Air to sell 40.39M shares at 51c in private placement

Beyond Air terminates loan, security agreements with Avenue Capital

XAIR

TipRanks

a year ago

Beyond Air terminates loan, security agreements with Avenue Capital

Beyond Air Provides LungFit® PH System to U.S. Naval Hospital Guam for Neonatal Critical Care in Partnership with TrillaMed

XAIR

GlobeNewswire

a year ago

Beyond Air Provides LungFit® PH System to U.S. Naval Hospital Guam for Neonatal Critical Care in Partnership with TrillaMed

Beyond Air Announces Termination of the Loan and Security Agreements with Avenue Capital

XAIR

GlobeNewswire

a year ago

Beyond Air Announces Termination of the Loan and Security Agreements with Avenue Capital

Beyond Air Announces $20.6 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules

XAIR

GlobeNewswire

a year ago

Beyond Air Announces $20.6 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules

Beyond Air to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

XAIR

GlobeNewswire

a year ago

Beyond Air to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Beyond Air First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

XAIR

Simply Wall St.

a year ago

Beyond Air First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Beyond Air® Reports Fiscal First Quarter 2025 Financial Results and Provides Corporate Update

XAIR

GlobeNewswire

a year ago

Beyond Air® Reports Fiscal First Quarter 2025 Financial Results and Provides Corporate Update

Beyond Air® Publishes Peer-Reviewed Journal Article in Scientific Reports with Clinical Data Showing Nitric Oxide was Safe and Beneficial Adjunct Therapy for Subjects with Viral Pneumonia

XAIR

GlobeNewswire

a year ago

Beyond Air® Publishes Peer-Reviewed Journal Article in Scientific Reports with Clinical Data Showing Nitric Oxide was Safe and Beneficial Adjunct Therapy for Subjects with Viral Pneumonia

Beyond Air® to Report First Fiscal Quarter 2025 Financial Results on August 6

XAIR

GlobeNewswire

a year ago

Beyond Air® to Report First Fiscal Quarter 2025 Financial Results on August 6

Beyond Air® To Participate in the BTIG Virtual Biotechnology Conference 2024

XAIR

GlobeNewswire

a year ago

Beyond Air® To Participate in the BTIG Virtual Biotechnology Conference 2024

Beyond Air® Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

XAIR

GlobeNewswire

a year ago

Beyond Air® Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Beyond Air® Appoints David Webster as Chief Commercial Officer

XAIR

GlobeNewswire

a year ago

Beyond Air® Appoints David Webster as Chief Commercial Officer

Getting smarter: FIA Launches 3-Day Smart Driving Challenge in Samarkand, Powered by Greater Than

XAIR

PR Newswire

a year ago

Getting smarter: FIA Launches 3-Day Smart Driving Challenge in Samarkand, Powered by Greater Than

3 Major Product Releases at 3Shape Discover Event

XAIR

PR Newswire

a year ago

3 Major Product Releases at 3Shape Discover Event

XAIR

Business Wire

a year ago

Net Asset Value(s)

Irish, Czechs hold EU vote after Dutch far-right gains

XAIR

AFP

a year ago

Irish, Czechs hold EU vote after Dutch far-right gains

Trade the Nvidia Stock Split? The Tried-and-True Method to Make the Best Profits on the Leading AI Stock

XAIR

Motley Fool

a year ago

Trade the Nvidia Stock Split? The Tried-and-True Method to Make the Best Profits on the Leading AI Stock

GPRC5D Targeting Drugs Market Opportunity and Clinical Trials Insight 2024: Insight on 15+ Drugs in Clinical Trials

XAIR

GlobeNewswire

a year ago

GPRC5D Targeting Drugs Market Opportunity and Clinical Trials Insight 2024: Insight on 15+ Drugs in Clinical Trials

[Latest] Global Virtual Reality In Gaming Market Size/Share Worth USD 103,244.7 Million by 2033 at a 16.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

XAIR

GlobeNewswire

a year ago

[Latest] Global Virtual Reality In Gaming Market Size/Share Worth USD 103,244.7 Million by 2033 at a 16.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Bitcoin ReoPro 3.0 Transforms Trading with AI Innovation

XAIR

PR Newswire

a year ago

Bitcoin ReoPro 3.0 Transforms Trading with AI Innovation

Beyond Cancer Presents First-in-Class Clinical Data Showing an Immunogenic Response in Subjects with r/r Unresectable Solid Tumors Treated with Ultra-High Concentration Nitric Oxide (UNO)

XAIR

GlobeNewswire

a year ago

Beyond Cancer Presents First-in-Class Clinical Data Showing an Immunogenic Response in Subjects with r/r Unresectable Solid Tumors Treated with Ultra-High Concentration Nitric Oxide (UNO)

Beyond Air Up 11%, Insiders Still Down After US$3.05m Purchase

XAIR

Simply Wall St.

a year ago

Beyond Air Up 11%, Insiders Still Down After US$3.05m Purchase

Beyond Air® Schedules Fiscal Year End 2024 Financial Results Conference Call and Webcast

XAIR

GlobeNewswire

a year ago

Beyond Air® Schedules Fiscal Year End 2024 Financial Results Conference Call and Webcast

Beyond Cancer Selected to Present on the Clinical Development of Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2024 American Society of Clinical Oncology Annual Meeting

XAIR

GlobeNewswire

a year ago

Beyond Cancer Selected to Present on the Clinical Development of Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2024 American Society of Clinical Oncology Annual Meeting

Beyond Air® Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants

XAIR

GlobeNewswire

a year ago

Beyond Air® Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants

Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2024

XAIR

GlobeNewswire

2 years ago

Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2024

After losing 76% in the past year, Atara Biotherapeutics, Inc. (NASDAQ:ATRA) institutional owners must be relieved by the recent gain

XAIR

Simply Wall St.

2 years ago

After losing 76% in the past year, Atara Biotherapeutics, Inc. (NASDAQ:ATRA) institutional owners must be relieved by the recent gain

Atara Biotherapeutics and Pierre Fabre Laboratories Announce Publication of Phase 3 ALLELE Tab-cel® Data in The Lancet Oncology

XAIR

Business Wire

2 years ago

Atara Biotherapeutics and Pierre Fabre Laboratories Announce Publication of Phase 3 ALLELE Tab-cel® Data in The Lancet Oncology

Will Connect Biopharma Holdings (NASDAQ:CNTB) Spend Its Cash Wisely?

XAIR

Simply Wall St.

2 years ago

Will Connect Biopharma Holdings (NASDAQ:CNTB) Spend Its Cash Wisely?

Vanda Pharmaceuticals Announces a U.S. Patent Allowance for PONVORY® (ponesimod) in the U.S.

XAIR

PR Newswire

2 years ago

Vanda Pharmaceuticals Announces a U.S. Patent Allowance for PONVORY® (ponesimod) in the U.S.

Veru to Report Fiscal 2024 First Quarter Financial Results on February 8, 2024

XAIR

GlobeNewswire

2 years ago

Veru to Report Fiscal 2024 First Quarter Financial Results on February 8, 2024

GoldMining Subsidiary, U.S. GoldMining, Announces Confirmatory Results, Including Highest Drill Intercept to Date at the Whistler Gold-Copper Project, Alaska

XAIR

PR Newswire

2 years ago

GoldMining Subsidiary, U.S. GoldMining, Announces Confirmatory Results, Including Highest Drill Intercept to Date at the Whistler Gold-Copper Project, Alaska

Duluth Holdings Inc. Announces Appointment of Heena Agrawal as Chief Financial Officer

XAIR

GlobeNewswire

2 years ago

Duluth Holdings Inc. Announces Appointment of Heena Agrawal as Chief Financial Officer

With 36% ownership, Athira Pharma, Inc. (NASDAQ:ATHA) has piqued the interest of institutional investors

XAIR

Simply Wall St.

2 years ago

With 36% ownership, Athira Pharma, Inc. (NASDAQ:ATHA) has piqued the interest of institutional investors

Beyond Air® Schedules Third Fiscal Quarter 2024 Financial Results Conference Call and Webcast

XAIR

GlobeNewswire

2 years ago

Beyond Air® Schedules Third Fiscal Quarter 2024 Financial Results Conference Call and Webcast

Autonomous truck developer TuSimple going private

XAIR

FreightWaves

2 years ago

Autonomous truck developer TuSimple going private

SuRo Capital Corp. Fourth Quarter and Fiscal Year 2023 Preliminary Investment Portfolio Update

XAIR

GlobeNewswire

2 years ago

SuRo Capital Corp. Fourth Quarter and Fiscal Year 2023 Preliminary Investment Portfolio Update

Avino’s Q4 and Full Year 2023 Production Results

XAIR

ACCESSWIRE

2 years ago

Avino’s Q4 and Full Year 2023 Production Results

Why Fast-paced Mover Fathom Holdings (FTHM) Is a Great Choice for Value Investors

XAIR

Zacks

2 years ago

Why Fast-paced Mover Fathom Holdings (FTHM) Is a Great Choice for Value Investors

Meridian Bet Provides Update on Corporate Progress and Pending Acquisition

XAIR

GlobeNewswire

2 years ago

Meridian Bet Provides Update on Corporate Progress and Pending Acquisition

American Resources Corporation's ReElement Technologies Announces January Slate of Conferences

XAIR

ACCESSWIRE

2 years ago

American Resources Corporation's ReElement Technologies Announces January Slate of Conferences

Saratoga Investment Corp. to Report Fiscal Third Quarter 2024 Financial Results and Hold Conference Call

XAIR

GlobeNewswire

2 years ago

Saratoga Investment Corp. to Report Fiscal Third Quarter 2024 Financial Results and Hold Conference Call

$Beyond Cancer™ Phase 1 Study Clears Cohort 1 in Patients with Advanced Relapsed or Refractory Unresectable Primary or Metastatic Cutaneous or Subcutaneous Solid Tumors$

XAIR

GlobeNewswire

2 years ago

Beyond Cancer™ Phase 1 Study Clears Cohort 1 in Patients with Advanced Relapsed or Refractory Unresectable Primary or Metastatic Cutaneous or Subcutaneous Solid Tumors

Investors in TAT Technologies (NASDAQ:TATT) have seen strong returns of 131% over the past three years

XAIR

Simply Wall St.

2 years ago

Investors in TAT Technologies (NASDAQ:TATT) have seen strong returns of 131% over the past three years

Beyond Air Independent Director Acquires 102% More Stock

XAIR

Simply Wall St.

2 years ago

Beyond Air Independent Director Acquires 102% More Stock

XAIR

Business Wire

2 years ago

Luna Acquires Silixa

Ring Energy Announces Successful Results of Senior Credit Facility Fall 2023 Redetermination and Final Payment for Founders Property Acquisition

XAIR

GlobeNewswire

2 years ago

Ring Energy Announces Successful Results of Senior Credit Facility Fall 2023 Redetermination and Final Payment for Founders Property Acquisition

Insider Buying: CEO Steven Lisi Acquires 77,775 Shares of Beyond Air Inc

XAIR

GuruFocus.com

2 years ago

Insider Buying: CEO Steven Lisi Acquires 77,775 Shares of Beyond Air Inc

XAIR

Associated Press Finance

2 years ago

Emergent Biosolutions: Q3 Earnings Snapshot

Insider Buying: SuRo Capital Corp's Mark Klein Acquires 49,885 Shares

XAIR

GuruFocus.com

2 years ago

Insider Buying: SuRo Capital Corp's Mark Klein Acquires 49,885 Shares

XAIR

Thomson Reuters StreetEvents

2 years ago

Q3 2024 AstroNova Inc Earnings Call

Emergent (EBS) Gets $75M BARDA Contract for Anthrax Vaccine

XAIR

Zacks

2 years ago

Emergent (EBS) Gets $75M BARDA Contract for Anthrax Vaccine

Shareholders in SuRo Capital (NASDAQ:SSSS) are in the red if they invested three years ago

XAIR

Simply Wall St.

2 years ago

Shareholders in SuRo Capital (NASDAQ:SSSS) are in the red if they invested three years ago

C&F Financial Corporation Announces Quarterly Dividend

XAIR

GlobeNewswire

2 years ago

C&F Financial Corporation Announces Quarterly Dividend

Destra Multi Alternative Fund Announces the Approval of an Amended and Restated Declaration of Trust

XAIR

Business Wire

2 years ago

Destra Multi Alternative Fund Announces the Approval of an Amended and Restated Declaration of Trust

Analysts Just Slashed Their Adaptive Biotechnologies Corporation (NASDAQ:ADPT) EPS Numbers

XAIR

Simply Wall St.

2 years ago

Analysts Just Slashed Their Adaptive Biotechnologies Corporation (NASDAQ:ADPT) EPS Numbers

Beyond Air® To Participate in the 35th Annual Piper Sandler Healthcare Conference

XAIR

GlobeNewswire

2 years ago

Beyond Air® To Participate in the 35th Annual Piper Sandler Healthcare Conference

XAIR

GuruFocus.com

2 years ago

LianBio (LIAN) Reports Q3 2023 Financial Results: Strategic Review in Progress Amid Clinical ...

Individual investors account for 54% of Genenta Science S.p.A.'s (NASDAQ:GNTA) ownership, while insiders account for 30%

XAIR

Simply Wall St.

2 years ago

Individual investors account for 54% of Genenta Science S.p.A.'s (NASDAQ:GNTA) ownership, while insiders account for 30%

LianBio Reports Third Quarter 2023 Financial Results and Provides Corporate Update

XAIR

GlobeNewswire

2 years ago

LianBio Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Beyond Air® Reports Financial Results for Second Quarter of Fiscal Year 2024

XAIR

GlobeNewswire

2 years ago

Latest Beyond Air Inc. (XAIR) News on August 24, 2025

Share on Social Networks: